Abstract
Intravesical administration of agents for the treatment of superficial bladder cancer often cause urological side effects (urgency, frequency, dysuria) and for doxorubicin these adverse effects are associated with enhanced urothelial contractions and also enhanced neurogenic detrusor contraction. Intravesical
| Original language | English |
|---|---|
| Pages | 205-205 |
| Number of pages | 1 |
| Publication status | Published - 2012 |
| Event | Joint ASCEPT- APSA 2012 Conference : Medication Safety - Sydney Convention and Exhibition Centre, Sydney, Australia Duration: 2 Dec 2012 → 5 Dec 2012 http://www.ascept-apsa.com/ |
Conference
| Conference | Joint ASCEPT- APSA 2012 Conference |
|---|---|
| Country/Territory | Australia |
| City | Sydney |
| Period | 2/12/12 → 5/12/12 |
| Internet address |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Depressed contractile responses of the bladder detrusor and urothelium/lamina propria following luminal administration of the cytotoxic agent gemcitabine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver